...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: New Apabetalone Fabry Disease Publication

Seems like a promisinf start.

From the research journal - These results suggest potential benefit of BD2-selective apabetalone in controlling inflammation and oxidative stress in FD, which will be further investigated in clinical trials.

Too bad Rvx can't get the financing to keep this science rolling.

Toinv

 

Share
New Message
Please login to post a reply